Pfizer Shot Halts Severe
Illness in Israel as Delta Spreads
By Alisa Odenheimer and Damian Shepherd
July 5, 2021, 8:59 AM GMT+1 Updated on July 5, 2021, 7:21 PM
GMT+1
Pfizer Inc.’s vaccine was less effective at keeping people from getting
the coronavirus in Israel in recent weeks, but it continues to
provide a strong shield against severe
Covid-19, according to government data.
The vaccine protected 64% of people against the illness
between June 6 and early July, down from a previous 94%. The drop was
observed as the delta variant was spreading in Israel, the Health Ministry said.
It also coincided with the lifting of virus restrictions at the start of June.
Despite the indications of increased infections, the data
also showed the shot is protecting people from severe illness. Its effectiveness at preventing hospitalization
fell to 93%, according to the Health Ministry, compared with at least 97%
in an earlier government study.
Delta, which first emerged in India, is spreading around the
globe as governments race to inoculate people. The mutation has forced some
countries to delay or rethink plans to loosen curbs on businesses, activity and
travel.
Pfizer spokeswoman Dervila Keane declined to comment on the
data from Israel. She pointed to research showing the vaccine’s continued
protection against new mutations -- just slightly reduced in some cases. The
evidence so far suggests that the vaccine “will continue to protect against
these variants,” she said.
Israel had one of the world’s most effective coronavirus
inoculation drives. About 57% of the population is now fully vaccinated.
Many new Covid-19 cases are among vaccinated people, according
to Ynet news service. Last Friday, 55%
of the newly infected had been vaccinated, the website said. As of July 4,
there were 35 serious cases of coronavirus out of a population of 9.3 million,
compared with 21 on June 19.
The government plans to study vaccinated individuals who
contracted the coronavirus, including factors such as age, pre-existing
conditions and inoculation dates, in order to evaluate the efficacy of the
vaccine and the rate at which it wears off, the prime minister’s office said.
The government is considering reinstating additional
restrictions after restoring a mandate to wear masks indoors in public spaces.
No decision has been on recommending a third dose of vaccine, the health
ministry said.
Pfizer Chief Executive
Officer Albert Bourla has said people will likely need a third dose within 12
months of getting fully protected.
https://www.bloomberg.com/news/articles/2021-07-05/israel-sees-decline-in-pfizer-vaccine-efficacy-rate-ynet-says
No comments:
Post a Comment